
More Evidence Ties Diabetes Meds to Lower Dementia Risk
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a significantly lower risk of dementia and Alzheimer's disease-related dementia (ADRD), findings from two new studies …